Observational studyMultiple sclerosis (Houndmills, Basingstoke, England)2018

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.

Cyra E Leurs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.